Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Velcade Double Entendre Raises Red Flags At FDA Over Reminder Ads

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency cites Millennium and Romark for misleading promotions.

You may also be interested in...



FDA Is Listening: Adolor Cited For Downplaying REMS At Conference

A company representative's oral statement that the REMS for the gastrointestinal surgery recovery drug Entereg is "due to logistics" was unacceptable, DDMAC letter says.

FDA Is Listening: Adolor Cited For Downplaying REMS At Conference

A company representative's oral statement that the REMS for the gastrointestinal surgery recovery drug Entereg is "due to logistics" was unacceptable, DDMAC letter says.

Takeda's Alogliptin Suffers Major Setback, Delaying Drug Launch Until 2012 Or Later

Negative news increases pressure on Japanese pharma's oncology subsidiary Millennium Pharmaceuticals to perform.

Topics

UsernamePublicRestriction

Register

PS142351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel